Melanonychia and mucocutaneous hyperpigmentation due to hydroxyurea use in an HIV-infected patient.
Laughon
S K
SK
Department of Dermatology, Medical College, Virginia Campus, Virginia Commonwealth University, Richmond, Virginia, USA.
Shinn
L L
LL
Nunley
J R
JR
D000998:Antiviral Agents / Q000627:therapeutic use; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D006918:Hydroxyurea / Q000009:adverse effects*; D017495:Hyperpigmentation / Q000139:chemically induced* / Q000473:pathology; D008548:Melanosis / Q000139:chemically induced / Q000473:pathology; D008875:Middle Aged; D009059:Mouth Diseases / Q000139:chemically induced* / Q000473:pathology; D009260:Nail Diseases / Q000139:chemically induced* / Q000473:pathology; D012871:Skin Diseases / Q000139:chemically induced* / Q000473:pathology
D000998:Antiviral Agents; D006918:Hydroxyurea